Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Icaritin/ZKAB 001

Next Previous
Drug Profile

Icaritin/ZKAB 001

Alternative Names: IC-162/ZKAB-001; Icaritin/STI-A1014; Icaritin/ZKAB001; PD-L1 monoclonal antibody - Lees Pharmaceutical Holdings; SNG-162/STI-A1014; SNG-162/ZKAB-001; STI-A1014/Icaritin; STI-A1014/SNG-162; ZKAB-001/IC-162; ZKAB-001/Icaritin

Latest Information Update: 28 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lees Pharmaceutical Holdings; Shenogen Pharma
  • Developer Lee's Pharmaceutical; Shenogen Pharma
  • Class Antineoplastics; Benzopyrans; Flavonoids; Monoclonal antibodies; Phenyl ethers; Small molecules
  • Mechanism of Action Estrogen receptor alpha modulators; Programmed cell death 1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 Dec 2021 No recent reports of development identified for research development in Cancer in China
  • 20 Nov 2017 Early research in Cancer in China (unspecified route)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top